# Real World Efficiency of Trastuzumab in Early Breast Cancer

> **NCT01894711** · — · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 2684 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Trastuzumab

## Key facts

- **NCT ID:** NCT01894711
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-11
- **Final completion:** 2013-05
- **Target enrollment:** 2684 (ACTUAL)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01894711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01894711, "Real World Efficiency of Trastuzumab in Early Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01894711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*